Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank92
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
44.95%
↑ 39146% vs avg
Percentile
P92
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-0.12%
Historical baseline
PeriodValue
Q4 202544.95%
Q3 20254.35%
Q2 2025-7.76%
Q1 2025-6.85%
Q4 2024-1.48%
Q3 2024-2.40%
Q2 202479.14%
Q1 2024-5.23%
Q4 2023-6.23%
Q3 20230.00%
Q2 20230.00%
Q1 2023-100.00%
Q4 20220.00%